NRXS compared with FENC: revenue, margins and what each company keeps, and the suppliers and customers both name

NRXSNeuraxis, Inc

Mkt capRevenueRevenue

FENCFennec Pharmaceuticals Inc.

Mkt capRevenueRevenue

Compare

NRXSNeuraxis, Inc

FENCFennec Pharmaceuticals Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

NRXS: latest quarter is a loss; flow not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only NRXS 1

—Masimounlistedcustomer

Shared 0

No shared counterparties.

Only FENC 2

—Inpharmusunlistedcustomer

—Norgineunlistedcustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

Price

rebased to 0%

NRXS, solidFENC, dashed

NRXSNeuraxis, Inc

6.64▲+0.61%

Mkt cap$82.6MRevenue$2MQ2 FY26Revenue$4MFY25

FENCFennec Pharmaceuticals Inc.

10.54▼−1.50%

Regular sessionNov 4 '26

Mkt cap$369.6MRevenue$18MQ2 FY26Revenue$45MFY25

Compare

Regular sessionNov 4 '26

NRXSNeuraxis, Inc

FENCFennec Pharmaceuticals Inc.

6.64▲+0.61%

Price

10.54▼−1.50%

$82.6M

Mkt cap

$369.6M

Q2 FY26$2M

Revenue

$18MQ2 FY26

FY25$4M

Revenue

$45MFY25

NRXS6.64▲+0.61%vsFENC10.54▼−1.50%Regular sessionNov 4 '26